Mitchell & Pahl Private Wealth LLC reduced its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 5.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,875 shares of the financial services provider’s stock after selling 553 shares during the quarter. Mitchell & Pahl Private Wealth LLC’s holdings in MetLife were worth $809,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Zurich Insurance Group Ltd FI acquired a new position in shares of MetLife in the 3rd quarter valued at $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in MetLife by 79.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after purchasing an additional 762,291 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in MetLife by 256.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after buying an additional 682,333 shares during the period. Nordea Investment Management AB boosted its holdings in MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after buying an additional 608,224 shares during the last quarter. Finally, Public Sector Pension Investment Board grew its position in shares of MetLife by 347.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock worth $30,384,000 after buying an additional 336,127 shares during the period. 94.99% of the stock is owned by institutional investors.
MetLife Stock Up 1.1 %
Shares of MET stock opened at $86.83 on Tuesday. The firm’s fifty day moving average price is $83.41 and its two-hundred day moving average price is $79.54. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05. The firm has a market capitalization of $60.12 billion, a P/E ratio of 17.51, a PEG ratio of 0.64 and a beta of 1.07.
MetLife Dividend Announcement
Analyst Ratings Changes
Several research analysts recently weighed in on the stock. TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Barclays lifted their target price on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Jefferies Financial Group lifted their price objective on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $89.92.
View Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Why Are These Companies Considered Blue Chips?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.